Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Confo Therapeutics financial update

    Confo Therapeutics N.V., Brussels, Belgium Business: High throughput screening, Antibodies Date announced: 2016-02-02 Note: Confo Therapeutics raised EUR3.7 million ($4 million) in a second close of a seed round, …

    Published on 2/8/2016
  • Galera Therapeutics financial update

    Galera Therapeutics Inc., Malvern, Pa. Business: Cancer, Other Date announced: 2016-02-04 Note: Galera raised an additional $5 million in a final close of a series B round, bringing the total raised in the round to $42 …

    Published on 2/8/2016
  • Imperial Innovations financial update

    Imperial Innovations Group plc (LSE:IVO), London, U.K. Business: Finance, Other Date announced: 2016-02-04 Note: Imperial Innovations proposed to raise up to L100 million ($142.5 million) through a placing of up to 23.5…

    Published on 2/8/2016
  • Medicxi Ventures financial update

    Medicxi Ventures, London, U.K. Business: Finance Date announced: 2016-02-02 Note: Medicxi Ventures closed its Medicxi Ventures 1 (MV1) fund at EUR210 million ($227.9 million). The fund will focus on early stage life …

    Published on 2/8/2016
  • Qiming Venture Partners financial update

    Qiming Venture Partners, Shanghai, China Business: Finance Date announced: 2016-02-01 Note: Qiming closed its Qiming Venture Partners V fund at $648 million. The firm will invest Fund V in Chinese healthcare, IT, …

    Published on 2/8/2016
  • Moleculin Biotech proposes IPO

    Moleculin Biotech Inc., Houston, Texas Business: Cancer Date announced: 2016-02-01 Type: IPO To be raised: Up to $12 million Shares: 2 million Price: $5-$6 Underwriters: Bonwick Capital Partners; Network 1 Financial …

    Published on 2/8/2016
  • Neos Therapeutics proposes follow-on

    Neos Therapeutics Inc. (NASDAQ:NEOS), Grand Prairie, Texas Business: Drug delivery, Neurology Date announced: 2016-01-29 Type: Follow-on To be raised: Up to $69 million Shares: TBD Price prior: $13.58 Underwriters: UBS;…

    Published on 2/8/2016
  • TearLab proposes follow-on

    TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Business: Diagnostic Date announced: 2016-02-01 Type: Follow-on To be raised: About $15 million Shares: TBD Price prior: $1.32 Underwriters: Stephens; Craig-Hallum…

    Published on 2/8/2016
  • KemPharm withdraws follow-on

    KemPharm Inc. (NASDAQ:KMPH), Coralville, Iowa Business: Neurology Date announced: 2016-02-03 Type: Follow-on Underwriters: Cowen; RBC Capital Markets; Canaccord; Oppenheimer Note: KemPharm withdrew its proposed follow-…

    Published on 2/8/2016
  • Editas Medicine amends IPO

    Editas Medicine Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics Date announced: 2016-01-25 Type: IPO To be raised: Up to $106.2 million Shares: 5.9 million Price: $16-$18 Underwriters: Morgan Stanley; …

    Published on 2/1/2016
  • Mapi-Pharma amends IPO

    Mapi-Pharma Ltd., Ness Ziona, Israel Business: Drug delivery, Generics Date announced: 2016-01-22 Type: IPO To be raised: Up to $53.1 million Shares: 3.1 million Price: $15-$17 Underwriters: JMP Securities; Maxim Group;…

    Published on 2/1/2016
  • Adagene completes venture financing

    Adagene Inc., Suzhou, China Business: Antibodies Date completed: 2016-01-28 Type: Venture financing Raised: $28 million Investors: GP Capital; New World TMT; Eight Roads Ventures China; F-Prime Capital; WuXi Corporate …

    Published on 2/1/2016
  • Adamis completes private placement of convertible preferred units

    Adamis Pharmaceuticals Corp. (NASDAQ:ADMP), San Diego, Calif. Business: Infectious, Inflammation Date completed: 2016-01-26 Type: Private placement of convertible preferred units Raised: $5 million Shares: 1.2 million …

    Published on 2/1/2016
  • Adicet completes venture financing

    Adicet Bio Inc., Menlo Park, Calif. Business: Cancer Date completed: 2016-01-27 Type: Venture financing Raised: $51 million Investors: OrbiMed Advisors; Novartis Venture Fund; Pontifax

    Published on 2/1/2016
  • Amarantus BioScience completes private placement of convertible preferred stock and warrants

    Amarantus BioScience Holdings Inc. (OTCQX:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Date completed: 2016-01-27 Type: Private placement of convertible preferred stock and warrants Raised: $1 …

    Published on 2/1/2016
  • Aprecia completes venture financing

    Aprecia Pharmaceuticals Co., Langhorne, Pa. Business: Drug delivery, Neurology Date completed: 2016-01-27 Type: Venture financing Raised: $35 million Investors: Deerfield Management; JW Asset Management LLC Note: The …

    Published on 2/1/2016
  • CARsgen completes venture financing

    CARsgen Therapeutics Co. Ltd., Shanghai, China Business: Cancer Date completed: 2016-01-25 Type: Venture financing Raised: $30 million Investors: KTB; Jolly Innovation Ventures; Kaitai Capital; JIC GenesisFountain …

    Published on 2/1/2016
  • Codiak BioSciences completes venture financing

    Codiak BioSciences Inc., Cambridge, Mass. Business: Cancer, Diagnostic Date completed: 2016-01-26 Type: Venture financing Raised: $61 million Investors: Arch Venture Partners; Flagship Ventures; Fidelity; Alaska …

    Published on 2/1/2016
  • CosmosID completes venture financing

    CosmosID Inc., Rockville, Md. Business: Bioinformatics, Genomics, Diagnostic Date completed: 2016-01-27 Type: Venture financing Raised: $6 million Investors: Applied Value Group; private investors

    Published on 2/1/2016
  • Emmaus Life Sciences completes venture financing

    Emmaus Life Sciences Inc., Torrance, Calif. Business: Hematology, Gastrointestinal Date completed: 2016-01-26 Type: Venture financing Raised: $1.7 million Investor: Korea Bio Medical Science Institute

    Published on 2/1/2016
  • Halozyme completes debt financing

    Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Date completed: 2016-01-26 Type: Debt financing Raised: $150 million Investors: Pharmakon Advisors; Athyrium…

    Published on 2/1/2016
  • Inivata completes venture financing

    Inivata Ltd., Cambridge, U.K. Business: Genomics, Cancer Date completed: 2016-01-26 Type: Venture financing Raised: L31.5 million ($44.9 million) Investors: Imperial Innovations Group plc; Cambridge Innovation Capital …

    Published on 2/1/2016
  • Jan Medical completes venture financing

    Jan Medical Inc., Mountain View, Calif. Business: Diagnostic, Neurology Date completed: 2016-01-25 Type: Venture financing Raised: $7.5 million Investor: Brainlab

    Published on 2/1/2016
  • LogicBio completes venture financing

    LogicBio Therapeutics Inc., Foster City, Calif. Business: Gene/Cell therapy, Hematology, Infectious Date completed: 2016-01-13 Type: Venture financing Raised: $4 million Note: LogicBio raised $4 million of a planned $5.…

    Published on 2/1/2016
  • Moberg Pharma completes bond

    Moberg Pharma AB (SSE:MOB), Bromma, Sweden Business: Dermatology, Neurology Date completed: 2016-01-25 Type: Bond Raised: SEK300 million ($35 million) Note: The five-year senior unsecured bond bears a floating interest …

    Published on 2/1/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993